Rakoski J
Dermatologische Klinik und Poliklinik der Technischen Universität München.
Z Hautkr. 1988;63 Suppl 4:26-30.
In appropriate cases of diseases mediated by IgE, specific hyposensitization may be a successful way of treatment. According to prospective studies, the risk of side effects ranges between 0.1 and 1% per injection. We report on cases with fatal outcome and suggest suitable strategies in order to avoid serious complications.
在由IgE介导的疾病的适当病例中，特异性减敏疗法可能是一种成功的治疗方法。根据前瞻性研究，每次注射的副作用风险在0.1%至1%之间。我们报告了一些致命病例，并提出了合适的策略以避免严重并发症。
